Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare, keratinizing or non-keratinizing squamous cell carcinoma arising from the mucosal epithelium of the nasal cavity or the paranasal sinuses. It affects most often the maxillary sinus. Less frequently, it arises from the nasal cavity, ethmoid sinus, sphenoid sinus, and frontal sinus. Symptoms include nasal fullness, epistaxis, rhinorhea, pain, and paresthesia. Patients with nasal squamous cell carcinoma usually present earlier than patients with maxillary sinus carcinoma and have a better prognosis compared to the latter group.
Biomarker and diagnostic research for nasal cavity and paranasal sinus squamous cell carcinoma has been reported in the published literature.
No clinical trials have been registered for nasal cavity and paranasal sinus squamous cell carcinoma.
55 publications have been identified in PubMed for nasal cavity and paranasal sinus squamous cell carcinoma. Research spans Review / Meta-Analysis (36%), Case Report / Case Series (22%), and Basic Science / Preclinical (15%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 20 | 36% |
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 12:34 AM UTC
Patient case studies |
12 |
22% |
Laboratory research | 8 | 15% |
Disease patterns and progression | 8 | 15% |
Clinical study results | 4 | 7% |
Testing and diagnosis research | 3 | 5% |
Chen SF (2026). [PMID: 41467362](https://pubmed.ncbi.nlm.nih.gov/41467362/). *Head Neck*. [Epidemiology / Natural History]
Speakman GC (2026). [PMID: 41173400](https://pubmed.ncbi.nlm.nih.gov/41173400/). *Hum Pathol*. [Review / Meta-Analysis]
Brame L (2026). [PMID: 41876393](https://pubmed.ncbi.nlm.nih.gov/41876393/). *Cancer Med*. [Epidemiology / Natural History]
Kabongo CM (2026). [PMID: 42090991](https://pubmed.ncbi.nlm.nih.gov/42090991/). *Oral Oncol*. [Epidemiology / Natural History]
Chelvarajah RC (2026). [PMID: 41816946](https://pubmed.ncbi.nlm.nih.gov/41816946/). *Head Neck*. [Basic Science / Preclinical]
Wang P (2026). [PMID: 41593888](https://pubmed.ncbi.nlm.nih.gov/41593888/). *Ann Med*. [Review / Meta-Analysis]
Hassan CH (2026). [PMID: 41720745](https://pubmed.ncbi.nlm.nih.gov/41720745/). *Eur Ann Otorhinolaryngol Head Neck Dis*. [Review / Meta-Analysis]
Feng L (2026). [PMID: 41664144](https://pubmed.ncbi.nlm.nih.gov/41664144/). *World J Surg Oncol*. [Basic Science / Preclinical]
Duprez F (2026). [PMID: 42038372](https://pubmed.ncbi.nlm.nih.gov/42038372/). *Front Oncol*. [Review / Meta-Analysis]
Bitar G (2026). [PMID: 42095034](https://pubmed.ncbi.nlm.nih.gov/42095034/). *J Neurol Surg B Skull Base*. [Basic Science / Preclinical]